Earlier this week I got an email from a colleague who I consider one of the best marketers I have ever worked with telling me that she was going to “take a package” and leave pharma marketing. I wish I could say that this doesn’t happen often, but it’s happening way too much and in my opinion the industry can’t continue to lose talent like this and replace them with people who have MBA’s and are afraid to push the envelope within our regulated environment.
POST SUMMARY: The idea that the reason for the decline in violation letters from the FDA is due to the FDA being afraid to take action in my opinion is very weak. Rather, I think it’s because both DTC marketers are playing it safe and cuts to FDA staff via budget tightening.
POST SUMMARY: 2014 is a banner year – producing the least number of letters by far – 10. Does this mean that DTC marketers are failing to push the envelope or is the FDA shorthanded when it comes to enforcement?
POST SUMMARY: While few would dispute that the pace of innovation has picked up, the outlook varies from one company to another — and many appear to be relying more on mergers and acquisitions than homegrown R&D to deliver new products. A record $250bn worth of deals was struck in 2014, and bankers and executives predict more this year as companies tap plentiful cash and cheap credit. But, eventually there won’t be as many companies to purchase and once again the focus is going to turn on marketing to meet sales goals.
While few would dispute that the pace of innovation has picked up, the outlook varies from one company to another — and many appear to be relying more on mergers and acquisitions than homegrown R&D to deliver new products. According to a report by Deloitte last month, return on investment from R&D rose in 2014 for the first time since 2010, to 5.5 per cent, up from 5.1 per cent the previous year.￼
POST SUMMARY: I spent a lot of time this year leading qualitative research along with analyzing quantitative research. I keep all the research report findings in a binder and while it’s true that a lot of the insights can’t be applied across all health conditions there are some common needs/wants. Here are some of the most common..
To all my readers; have a wonderful holiday with a lot of memories. Because of the products we develop and market a lot of people are able to enjoy the season with friends and family. However, we should not forget that there is a lot of work to do to earn the trust of patients, caregivers and HCP’s. In the end the best thank you we can ever get is knowing that somewhere, someone is loving longer with a better quality of life. Good medicine leads to good business.